Minerva Neurosciences
NERV
$2.37
Share price
-0.84%
Change (1 day)
-48.59%
Change (1 year)
Categories
Minerva Neurosciences (NERV) - Total assets
Total assets on the balance sheet as of December 2023 : $56.89 M
According to Minerva Neurosciences 's latest financial reports the company's total assets are $56.89 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Minerva Neurosciences - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $56.89 M | 3.29% |
| 2022-12-31 | $55.08 M | -28.57% |
| 2021-12-31 | $77.12 M | 33.83% |
| 2020-12-31 | $57.62 M | -25.64% |
| 2019-12-31 | $77.49 M | -44.3% |
| 2018-12-31 | $0.13 B | -24.26% |
| 2017-12-31 | $0.18 B | 38.18% |
| 2016-12-31 | $0.13 B | 60.99% |
| 2015-12-31 | $82.57 M | 20.64% |
| 2014-12-31 | $68.45 M | 134.62% |
| 2013-12-31 | $29.17 M | 13838.62% |
| 2012-12-31 | $0.2 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Incyte INCY | $6.78 B | 11,819.39% | 🇺🇸 USA |
 Dynavax Technologies
DVAX | $0.99 B | 1,652.37% | 🇺🇸 USA |
 Clovis Oncology CLVS | $0.34 B | 509.45% | 🇺🇸 USA |